These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1973290)

  • 1. Oral bioavailability of triamcinolone tablets and a triamcinolone diacetate suspension.
    Hochhaus G; Pörtner M; Barth J; Möllmann H; Rohdewald P
    Pharm Res; 1990 May; 7(5):558-60. PubMed ID: 1973290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of triamcinolone following oral administration].
    Pörtner M; Möllmann H; Barth J; Rohdewald P
    Arzneimittelforschung; 1988 Dec; 38(12):1838-40. PubMed ID: 3245858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triamcinolone diacetate nanoparticles, a sustained release drug delivery system suitable for parenteral administration.
    El-Samaligy M; Rohdewald P
    Pharm Acta Helv; 1982; 57(7):201-4. PubMed ID: 7122649
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of intramuscular triamcinolone and oral prednisone in the outpatient treatment of acute asthma: a randomized controlled trial.
    Schuckman H; DeJulius DP; Blanda M; Gerson LW; DeJulius AJ; Rajaratnam M
    Ann Emerg Med; 1998 Mar; 31(3):333-8. PubMed ID: 9506490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized depigmentation after steroid injection of a ganglion cyst on the hand.
    Stapczynski JS
    Ann Emerg Med; 1991 Jul; 20(7):807-9. PubMed ID: 1676570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lysyl oxidase and prolyl hydroxylase activity in glucocorticoid treated rats.
    Benson SC; LuValle PA
    Biochem Biophys Res Commun; 1981 Mar; 99(2):557-62. PubMed ID: 6112990
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bioavailability of an orally administered medroxyprogesterone acetate suspension.
    Antal EJ; Gillespie WR; Albert KS
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):257-9. PubMed ID: 6222996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug].
    Kurowski M
    Z Rheumatol; 1988; 47(1):37-42. PubMed ID: 3369245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
    Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
    Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of sulfadiazine solutions, suspensions, and tablets in humans.
    Meyer MC; Straughn AB; Ramachander G; Cavagnol JC; Biola Mabadeje AF
    J Pharm Sci; 1978 Dec; 67(12):1659-61. PubMed ID: 581498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of plasma and urinary canrenone for determination of bioavailability of spironolactone--comparison of tablets with solution/suspension.
    Tidd MJ; Ramsay LE; Shelton JR; Palmer RF
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):205-10. PubMed ID: 873663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterisation of fluids and soft foods frequently mixed with oral drug formulations prior to administration to children.
    Kersten E; Barry A; Klein S
    Pharmazie; 2016 Mar; 71(3):122-7. PubMed ID: 27183705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole.
    Petitcollin A; Crochette R; Tron C; Verdier MC; Boglione-Kerrien C; Vigneau C; Bellissant E; Lemaitre F
    Drug Metab Pharmacokinet; 2016 Oct; 31(5):389-393. PubMed ID: 27530708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
    Olguín HJ; Pérez CF; Pérez JF; Mendiola BR; Portugal MC; Chávez JB
    Biopharm Drug Dispos; 2006 Jul; 27(5):241-5. PubMed ID: 16586461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radio-immunological assay for triamcinolone in plasma.
    Loo JC; Jordan N
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):493-504. PubMed ID: 572576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of a pediatric amlodipine suspension.
    Lyszkiewicz DA; Levichek Z; Kozer E; Yagev Y; Moretti M; Hard M; Koren G
    Pediatr Nephrol; 2003 Jul; 18(7):675-8. PubMed ID: 12734745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of darunavir after administration of an oral suspension with low-dose ritonavir and with or without food.
    Kakuda TN; Sekar V; Lavreys L; De Paepe E; Stevens T; Vanstockem M; Vangeneugden T; Hoetelmans RM
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):346-52. PubMed ID: 27129006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.